The Week in Diabetes and Endocrinology April 17, 2026

About this episode

This episode covers six important stories in diabetes and endocrinology for healthcare professionals.

The Week in Diabetes & Endocrinology — Episode 003 | April 17, 2026 From Hormone Insight (hormoneinsight.com) Six stories this week that endocrinologists, diabetologists, and internists need to know. TIMESTAMPS: 0:00 — Introduction & This Week's Stories 1:15 — Automated Insulin Delivery in Type 2 Diabetes: A Landmark Trial Worth Unpacking 5:30 — Enlicitide: The First Oral PCSK9 Inhibitor (CORALreef Lipids) 9:30 — SCORED and Sotagliflozin: What the Trial Actually Tells Us 12:30 — Semaglutide in Type 1 Diabetes + Obesity (NEJM Evidence) 15:00 — Boehringer Ingelheim's Strategic Bet on Obesity + Liver Health 16:30 — Chronotype-Aligned Exercise: Timing May Matter as Much as Training 18:00 — Closing Thoughts REFERENCES & SHOW NOTES: ▸ AID in T2D (NEJM, 2IQP trial): https://doi.org/10.1056/NEJMoa2415948 ▸ Enlicitide CORALreef Lipids (Med): https://doi.org/10.1016/j.medj.2026.101097 ▸ CORALreef Lipids primary (NEJM): https://doi.org/10.1056/NEJMoa2511774 ▸ Semaglutide in T1D + obesity (NEJM Evidence): https://doi.org/10.1056/EVIDoa2500173 ▸ Chronotype-aligned exercise RCT (Open Heart): https://doi.org/10.1136/openhrt-2025-003573 ABOUT THIS PODCAST: A weekly evidence-based review of the…

People in this episode

Host: FWA

Topics covered

• Diabetes
• Endocrinology
• Obesity
• Insulin Delivery
• PCSK9 Inhibitor
• Exercise Timing

Keywords

• diabetes
• endocrinology
• insulin delivery
• obesity
• PCSK9 inhibitor
• exercise timing
• Sotagliflozin
• Semaglutide

Mentioned in this episode

Organizations: Hormone Insight, Boehringer Ingelheim

Products: Enlicitide, Semaglutide, Sotagliflozin

More episodes of Hormone Insight

• The Week in Endocrinology Oral Ozempic & Emerging Therapies · May 12, 2026 · 5 min
• Week in Diabetes & Endocrinology (May 4, 2026): AID in Pregnancy, Tirzepatide ICERs, AACE Signals, Dapagliflozin & Anemia, Hypoglycemia Models, Oat Diet Trial · May 5, 2026 · 16 min
• HORMONE INSIGHT -- THE WEEK IN DIABETES & ENDOCRINOLOGY -- Episode 004 | April 24, 2026 · April 24, 2026 · 14 min
• Episode 002: LDL Under 55 Wins Big, Medicare Covers GLP-1, and Second Weekly Insulin Emerges -- The Week in Diabetes & Endocrinology (April 10, 2026) · April 9, 2026 · 17 min
• The Week in Diabetes and Endocrinology -- April 3, 2026 · April 5, 2026 · 24 min
• Early Onset Type 2 Diabetes and Tirzepatide (SURPASS Post Hoc Analysis) · June 14, 2025 · 1 min